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Background: Diabetes mellitus (hereafter called diabetes) is considered to accelerate arteriosclerosis leading
to coronary heart disease and stroke. Thus, it is important to quantitatively estimate the extent of subclinical
arteriosclerosis. A new method called cardio-ankle vascular index (CAVI) is developed to reflect arterial stiffness
independently from blood pressure at the time of measurement. Then, we examined if CAVI scores could
discriminate the extent of arteriosclerosis between persons with prediabetes (or borderline diabetes) and with
diabetes among Japanese urban workers and their families.
Methods: Subjects were 9881 men and 12033 women of company employees and their families who participated
in cardiovascular disease screening in Japan. Persons having diabetes and prediabetes were defined based on the
criteria set by American Diabetes Association. CAVI scores were measured by VaSera VS-1000. We applied the
established age-sex specific cutoff points of CAVI scores above which were determined to be abnormally high or
advanced level of arteriosclerosis. To examine the association of prediabetes and diabetes with CAVI scores, CAVI
scores of screening participants were converted to a binary variable: 1 for less than cutoff points and 2 for equal
or greater than cutoff points or abnormally high CAVI scores. Logistic regression method was used to examine
the association of prediabetes and diabetes with CAVI scores after adjusting for major cardiovascular disease
(CVD) risk factors.
Results: Prevalence of abnormally high CAVI scores was significantly higher after 40 years of age among persons with
diabetes than either among persons with prediabetes or among normal persons in both genders. Significantly elevated
odds ratios (ORs) of abnormally high CAVI scores appeared among persons with prediabetes: 1.29 (95 % confidence
interval (CI), 1.11-1.48) for men and 1.14 (CI, 1.01-1.28) for women, and among persons with diabetes: 2.41 (CI, 1.97-2.95)
for men and 2.52 (CI, 1.94-3.28) for women.
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Conclusions: The extent of subclinical arteriosclerosis (including arterial stiffness and atherosclerosis) was moderately
enhanced among persons with prediabetes and was further advanced among persons with diabetes. Thus, it is important
to introduce earlier interventions for changing lifestyle and diet of persons with prediabetes in order to prevent them
from developing diabetes and further advancing arteriosclerosis.
Keywords: Cardio-ankle vascular index (CAVI), Diabetes mellitus, Prediabetes, Arteriosclerosis, Epidemiology, Japanese
populationBackground
One of the most serious complications among person
with diabetes is the deterioration of arterial system or
the acceleration of arteriosclerosis which could not be
easily measured in the past. One method to quantita-
tively estimate the extent of arteriosclerosis is the use of
the pulse wave velocity (PWV). The idea on the associ-
ation of PWV with arteriosclerosis is traced back to an
experiment using artificial blood vessels conducted by
Moens in 1878 [1]. Then, Bramwell and colleagues
showed that PWV depends on the modulus of arterial
volume elasticity by experiments in 1922-23 [1–5]. Their
experimental results have been a basis for the develop-
ment of the measurement device PWV-200 (Fukuda-
Denshi Co., Tokyo) which measures PWV propagating
through the aorta (thorax, abdomen, and part of com-
mon iliac artery) from the aortic valve to the femoral
pulsation point, as described by Hasegawa in 1970 [6].
Because PWV is highly correlated with diastolic blood
pressure, Hasegawa developed a nomogram showing the
association between diastolic blood pressure and PWV.
He proposed an adjustment to any measured PWV
values at 80 mmHg. As a result, such an adjustment was
built into the PWV-200 machine. This is an important
step allowing clinicians and researchers to compare
PWV values between individuals and between popula-
tions. Namekata et al. conducted cardiovascular disease
prevention screening in Seattle and found that PWV
was positively and significantly associated with aging
(≥60 years of age), hypertension, diabetes, the ratio of
total cholesterol to high density lipoprotein cholesterol,
ex-smokers and negatively and significantly with alco-
hol consumption among Japanese Americans [7]. In
addition, they had similar findings among Japanese
urban workers [8].
To overcome some technical difficulty for measuring
PWV, the cardio-ankle vascular index (CAVI) was de-
veloped as a new indicator of arteriosclerosis in 2004
[9]. CAVI scores quantitatively reflect arteriosclerosis
of the aorta, femoral and tibial arteries based on
Bramwell-Hill’s equation [1] and stiffness parameter
[10] which is allowed to be converted from PWV
propagating from the aortic valve to ankle. Some re-
searchers proposed to use CAVI scores as an indicatorof atherosclerosis. Nakamura et al. found a strong as-
sociation of CAVI with the presence of severity of cor-
onary atherosclerosis based on their ordinal logistic
regression analysis [11]. Kadota et al. suggested the
use of CAVI as a screening tool for atherosclerosis
based on their findings from the general population
study of 1,014 adults showing strong significant asso-
ciations of CAVI scores with carotid intima-media
thickness and with homocysteine after adjustment for
age and sex [12]. Thus, it is considered that CAVI
scores reflect arterial stiffness, atherosclerosis and ar-
teriosclerosis of which conditions are overlapping and
inseparable. We use CAVI scores to represent the ex-
tent of subclinical arteriosclerosis in this paper but it
is inclusive of arterial stiffness and atherosclerosis.
To practically use CAVI as a diagnostic tool for
determining the extent of arteriosclerosis, our previ-
ous study established the baseline CAVI scores by age
and gender among cardiovascular disease (CVD) risk-
free persons [13]. In our present study we measured
CAVI scores and identified persons with abnormally
high CAVI scores in Japanese urban workers and
their families based on the criteria developed by our
studies [13, 14], and then examined the extent of sub-
clinical arteriosclerosis among persons with prediabe-
tes and among persons with diabetes mellitus after
making adjustment for major cardiovascular disease
(CVD) risk factors.Methods
Subjects
Subjects for the study were recruited from January 2006
to May 2009 through the screening program at Japan
Health Promotion Foundation which has been conduct-
ing cardiovascular disease and cancer screening through-
out major cities in Japan. Subjects were company
employees and their family members: 9,881 men and
12,033 women between 17 and 87 years of age. Follow-
ing Japan’s Personal Information Protection Law, the use
of anonymized screening data for research purpose was
approved by the board of Japan Health Promotion Foun-
dation. The study was approved by the board of Pacific
Rim Disease Prevention Center.
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Following the recommendation from American Diabetes
Association [15], persons having diabetes were defined
as those having medical history of diabetes and/or taking
medication of diabetes and/or whose fasting plasma glu-
cose were equal to or higher than 126 mg/dl and/or
whose hemoglobinA1c (HbA1c) were equal to or higher
than 6.5 % in NGSP value (48 mmol/mol in IFCC). Per-
sons with the state of prediabetes were defined as those
whose fasting plasma glucose was from 100 mg/dl to
125 mg/dl and/or whose HbA1c was from 5.7 % to
6.4 % in NGSP value (39 mmol/mol to 47 mmol/mol in
IFCC). Persons defined as “normal” were those without
diabetes and prediabetes.
Clinical measurements
Blood was drawn from subjects after a 12 h fast. The fol-
lowing measurements were made: total cholesterol (TC)
and triglycerides (TG) by enzymatic assay; high density
lipoprotein cholesterol (HDL-C) by modified enzymatic
method; glucose by hexokinase glucose-6-phosphate de-
hydrogenate assay; and glyco-hemoglobin A1c (HbA1c)
by latex agglutination.
Following the guideline released by American Heart
Association in 2007 [16], persons having hypertension
were defined as those having medical history of hyper-
tension and/or taking hypertension drugs and/or whose
systolic blood pressure (SBP) was equal to or higher than
140 mmHg and/or whose diastolic blood pressure (DBP)
was equal to or higher than 90 mmHg.
Cardio-ankle vascular index
CAVI, a stiffness and arteriosclerosis indicator of thorax,
abdomen, common iliac, femoral and tibial arteries, was
measured by VaSera VS-1000 manufactured by Fukuda-
Denshi Company, LTD (Tokyo, Japan).
As illustrated by Shirai et al. [9], the scale conversion
from PWV to CAVI is performed by the following
formula:
CAVI ¼ a 2ρ=ΔPð Þ x ln Ps=Pdð ÞPWV2  þ b
where Ps and Pd are systolic and diastolic blood pres-
sure values, respectively, PWV is the pulse wave velocity
between heart and ankle, ΔP is Ps-Pd, ρ is blood density,
and a and b are constants. This equation was derived
from Bramwell-Hill’s equation [1] and stiffness param-
eter [10]. Scale conversion constants are determined so
as to match CAVI with PWV by Hasegawa’s method [6].
These measurements and calculations are automatically
made in VaSera VS-1000.
In the previous study we established the age-sex spe-
cific cutoff points of CAVI scores above which were
determined to be abnormally high or advanced level ofarteriosclerosis [14]. The cutoff points are (mean of
CAVI + one standard deviation ) among CVD risk-free
subjects: 7.39 for 20-29 years of age, 7.80 for 30-39 years
of age, 8.29 for 40-49 years of age, 8.83 for 50-59 years
of age, 9.54 for 60-69 years of age, and 10.35 for 70 years
of age and over among men; and 7.23 for 20-29 years of
age, 7.42 for 30-39 years of age, 7.95 for 40-49 years of
age, 8.52 for 50-59 years of age, 8.98 for 60-69 years of
age, and 9.46 for 70 years of age and over among
women. To apply the logistic regression method for
examining the association of prediabetes and diabetes
with CAVI scores, CAVI scores of screening participants
were converted to a binary variable: 1 for less than cutoff
points and 2 for equal or greater than cutoff points or
abnormally high CAVI scores.
Questionnaire
A short self-administered questionnaire was filled out by
each subject during the screening. It contains questions
on medical history and lifestyle factors such as smoking
habit and alcohol consumption.
Statistical methods
All statistical analyses were performed gender-specifically.
To examine characteristics of study participants by dia-
betes status, Student’s t-tests and chi-square tests were
conducted for detecting significant differences in means
and in prevalence, respectively, between persons with nor-
mal status and persons with prediabetes and diabetes.
Cochran-Armitage test for linear trend was applied to
evaluate the dose-dependent association between the de-
gree of glycemic status and the prevalence of abnormally
high CAVI scores. Crude, age-adjusted and multivariable-
adjusted odds ratios (OR) and the 95 % confidence inter-
vals (CI) of abnormally high CAVI scores according to
diabetic status were calculated in logistic regression
models, with normal persons who were treated as the
reference category. In the age-adjusted model, age was
entered as a variable of 10-year interval categories
(50-59, 60-69, 70+ vs. <50). The multivariable model
was further adjusted for major CVD risk factors
including hypertension (yes vs. no), HDL-C (≥40 mg/
dl vs. <40 mg/dl for males, ≥50 mg/dl vs. <50 mg/dl
for females), triglycerides (150-199 mg/dl, ≥200 mg/dl
vs. <150 mg/dl), BMI (20-22.9, 23-24.9, 25-27.9, 28-
29.9, 30+ vs. <20), drinking habit (≤4 times/week, ≥5
times/week vs. non-drinkers), and smoking habit (ex-
smokers, current smokers vs. non-smokers).
Results
Characteristics of study participants by age and gender
were described in our previous paper [14]. We briefly
summarize those here. It is observed that the averages
for both systolic and diastolic blood pressure and CAVI
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ders with an exception of men’s diastolic blood pressure
after 60 years of age of which averages slightly de-
creased. Almost all averages of clinical indicators in-
creased until 60 years of age except HDL-C of which
averages were at the same level in both genders. Striking
differences in averages of clinical indicators between
genders are observed and are unfavorable for men in
terms of cardiovascular disease risk. BMI averages
ranged from 22.3 to 24.2 among men and from 20.4 to
22.9 among women. Greater prevalence of drinkers and
smokers was observed in men than in women. Preva-
lence of drinkers and smokers was greater in younger
women than in older women.
Table 1 shows characteristics of study participants by
diabetes status. Averages of all variables in both gendersTable 1 Characteristics of study participants by diabetes status
Normal
Sample size Men 7,202
Women 8,947
mean ± SD (t
Age Men 43 ± 13
Women 44 ± 12
Systolic blood pressure Men 125 ± 14
Women 118 ± 15
Diastolic blood pressure Men 76 ± 11
Women 70 ± 10
Total cholesterol (mg/dl) Men 205 ± 35
Women 209 ± 37
HDL-C (mg/dl) Men 61 ± 17
Women 77 ± 18
Triglycerides (mg/dl) Men 129 ± 112
Women 78 ± 52
CAVI Men 7.43 ± 0.99
Women 7.24 ± 0.92
Body Mass Index (kg/m2) Men 23.5 ± 3.2
Women 21.3 ± 3.0
Prevalence (%








Note: Student’s t-tests and chi-square tests were conducted by comparing means a
with prediabetes or persons with diabetes
p-value: *< 0.05, **< 0.01, ***< 0.001were lowest in normal, highest in diabetes, and middle
in prediabetes, except averages of HDL-C which were in
the reverse order. Prevalence of abnormally high CAVI
scores was lowest in normal, highest in diabetes, and
middle in prediabetes.
Prevalence of abnormally high CAVI scores is shown
according to the status of prediabetes and diabetes by
age and gender in Table 2. It is observed that such
prevalence was higher after 40 years of age among per-
sons with diabetes than either among persons with pre-
diabetes or among normal persons in both genders.
Table 3 shows odds ratios (ORs) of abnormally high
CAVI scores in association with prediabetes and diabetes
as compared with the reference of normal CAVI scores:
(1) without an adjustment for confounding factors




51 ± 10 (t = 28.11***) 56 ± 10 (t = 26.72***)
51 ± 9 (t = 27.54***) 55 ± 9 (t = 16.60***)
131 ± 15 (t = 15.12***) 136 ± 18 (t = 18.53***)
125 ± 15 (t = 21.58***) 132 ± 18 (t = 16.43***)
81 ± 11 (t = 17.26***) 82 ± 11 (t = 14.03***)
73 ± 11 (t = 14.32***) 77 ± 12 (t = 11.19***)
215 ± 35 (t = 8.07***) 214 ± 37 (t = 4.54***)
225 ± 38 (t = 18.34***) 230 ± 40 (t = 9.21***)
60 ± 17 (t = 3.90***) 57 ± 18 (t = 5.81***)
75 ± 19 (t = 3.63***) 70 ± 18 (t = 6.66***)
156 ± 139 (t = 8.96***) 170 ± 133 (t = 8.82***)
95 ± 56 (t = 14.18***) 121 ± 80 (t = 14.30***)
7.97 ± 0.96 (t = 21.28***) 8.49 ± 1.11 (t = 26.08***)
7.62 ± 0.89 (t = 18.93***) 8.09 ± 1.02 (t = 16.38***)
24.6 ± 3.3 (t = 13.56***) 25.1 ± 3.9 (t = 12.46***)
22.5 ± 3.6 (t = 17.79***) 24.3 ± 4.2 (t = 17.53***)
) (chi-square statistics)
18.5 (χ2 = 43.41***) 30.4 (χ2 = 157.25***)
18.9 (χ2 = 21.01***) 34.2 (χ2 = 85.95***)
77.9 (χ2 = 10.62**) 72.7 (χ2 = 0.81)
36.9 (χ2 = 34.05***) 23.0 (χ2 = 52.65***)
29.5 (χ2 = 33.23***) 31.7 (χ2 = 24.29***)
7.6 (χ2 = 35.23***) 9.1 (χ2 = 10.24**)
43.1 (χ2 = 33.23***) 41.4 (χ2 = 24.29***)
9.4 (χ2 = 35.23***) 7.0 (χ2 = 10.24**)
nd prevalence respectively between persons with normal status and persons
Table 2 Prevalence (%) of abnormally high CAVI scores by status of prediabetes and diabetes mellitus
Age ≤29 30-39 40-49 50-59 60-69 70+
Men
Normal prevalence 6.0 10.9 13.2 21.5 12.8 11.8
persons at risk 1042 2338 1731 1235 704 152
Prediabetes
prevalence 9.1 16.3 15.5 23.3 16.9 12.1
persons at risk 22 270 555 738 350 66
Diabetes
prevalence __ 11.8 19.1 43.7 26.9 20.3
persons at risk 2 51 110 263 193 59
χ2value for linear trend (p-value) __ 4.25 (0.039) 4.31 (0.038) 39.9 (0.000) 21.16 (0.000) 2.14 (0.144)
Women
Normal prevalence 5.9 14.8 11.6 19.8 23.2 33.9
persons at risk 892 2657 2340 2235 711 112
Prediabetes
prevalence __ 16.9 12.4 21.9 23.3 30.5
persons at risk 11 413 728 1184 361 59
Diabetes
prevalence __ __ 20.3 37.7 42.1 __
persons at risk 2 19 59 159 76 15
χ2value for linear trend (p-value) __ __ 2.12 (0.145) 17.53 (0.000) 6.24 (0.012) __
Note: ― indicates that the sample size was too small to obtain meaningful prevalence
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further added to logistic regression analysis. As more
confounding factors were adjusted, odds ratios de-
creased in both prediabetes and diabetes mellitus ex-
cept ORs of prediabetes in women indicating that ORs
after adjusting for ages and for CVD risk factors were
almost identical and lower than crude OR. After
adjusting for major CVD risk factors, significantly ele-
vated ORs appeared among persons with prediabetes:Table 3 Estimated risk of having abnormally high CAVI scores in ass






(1) Crude 1.56 *** 1.36
(2) Adjusted for age 1.32 *** 1.15
(3) Adjusted for CVD risk factors 1.29 ** 1.11
Women
(1) Crude 1.30 *** 1.16
(2) Adjusted for age 1.12 0.99
(3) Adjusted for CVD risk factors 1.14 * 1.01
Note: OR Odds ratio, CI Confidence interval; *p < 0.05, **p < 0.01, ***p < 0.001; (1) Pr
analysis. (2) Age breakdowns (<50, 50-59, 60-69, ≥70 years of age) were added to lo
BMI, drinking, and smoking) were further added to logistic regression analysis1.29 (95 % confidence interval (CI), 1.11-1.48) for men
and 1.14 (CI, 1.01-1.28) for women, and among per-
sons with diabetes: 2.41 (CI, 1.97-2.95) for men and
2.52 (CI, 1.94-3.28) for women.
Discussion
In the present cross-sectional study of Japanese urban
workers and their families, prevalence of abnormally high






1.78 2.98 *** 2.50 3.56
1.51 2.38 *** 1.97 2.88
1.48 2.41 *** 1.97 2.95
1.45 2.90 *** 2.29 3.66
1.25 2.19 *** 1.72 2.78
1.28 2.52 *** 1.94 3.28
ediabetes or diabetes was included alone as a covariate in logistic regression
gistic regression analysis. (3) Other CVD risk factors (hypertension, HDL-C, TG,
Namekata et al. BMC Cardiovascular Disorders  (2016) 16:52 Page 6 of 7the advancing degree of diabetic status both in men and
in women. Compared with normal persons, significantly
elevated odds ratios of abnormally high CAVI scores were
observed not only in persons with diabetes but also in
those with prediabetes.
With regard to the validity to use CAVI scores as an
indicator of arteriosclerosis, Otsuka examined 72 de-
ceased patients’ antemortem PWV (which is a basis for
deriving CAVI scores) and pathological changes mea-
sured by the diffuse fibrotic thickening, formation of
atheroma and calcification in the wall of their aorta. He
reported multiple regression coefficient R = 0.810 be-
tween PWV and scores of those pathological changes
[17]. In addition, other researchers reported that CAVI
scores were significantly associated with coronary ath-
erosclerosis [11], with carotid intima-media thickness
and with homocysteine [12]. Thus, the use of CAVI
scores derived from PWV values is valid to estimate the
extent of arteriosclerosis.
VaSera VS-1000, which was used in our study, was de-
signed to measure CAVI scores independent of blood
pressure at the time of CAVI score measurement and
CAVI scores represent the extent of arteriosclerosis be-
tween the aortic valve and the ankle. We have shown
biological aging of the major artery by measuring CAVI
scores in the CVD risk-free group and disease-related
pathological aging of the major artery in the CVD high-
risk group [13]. CAVI scores allow us to evaluate the ex-
tent of arteriosclerosis in the major arteries between the
aortic valve and the ankle, to screen persons with sub-
clinical stage of CVD, and provide an opportunity to
modify diet and lifestyle to improve CAVI scores as re-
ported by Satoh et al [18]. Thus, the use of CAVI scores
potentially leads to savings on high treatment costs and
to prolonging many productive lives.
Namekata et al. showed significant odds ratios of the
abnormally high aortic pulse wave velocity (PWV, an in-
dicator of arteriosclerosis reflecting stiffness of artery
and atherosclerosis) in an association with diabetes
among Japanese Americans and among native Japanese
(3.66 and 2.43, respectively) [8]. Namekata et al. ob-
served that odds ratios of abnormally high CAVI scores
in an association with diabetes after making adjustment
for ages were 10.02 for men and 8.42 for women, com-
pared with those who did not have diabetes [14]. In our
recent study significant ORs of prediabetes and diabetes
were observed in association with most CVD risk factors
including age, hypertension, triglycerides ≥ 200 mg/dl
and BMI ≥ 25 in both genders [19]. Our results imply
much faster advancement of arteriosclerosis among per-
sons both with prediabetes and with diabetes than in the
normal persons.
In our present study it is shown that prevalence of
abnormally high CAVI scores has an increasing trendwith an age increase in all three groups of non-diabetes
normal persons, prediabetes and diabetes (Table 2). Our
results show that comparing with persons with normal
CAVI scores, estimated risks of abnormally high CAVI
scores in association with prediabetes and with diabetes
were 1.29 times higher and 2.41 times higher, respect-
ively, in men and were 1.14 times higher and 2.52 times
higher, respectively, among women (Table 3). Our study
results have confirmed the association between predia-
betes and arteriosclerosis and the much stronger asso-
ciation between diabetes and arteriosclerosis estimated
by CAVI scores.
A limitation of this study is that it is an observational
and cross-sectional study. Thus, we cannot tell how
many persons with prediabetes will develop diabetes or
will return to normal in their blood glucose levels or/
and HbA1c levels. The strengths of this study are having
the large sample size and being able to adjust for many
CVD risk factors with enough statistical power to exam-
ine the association of CAVI scores with prediabetes and
diabetes mellitus.
Conclusion
In conclusion, both prediabetes and diabetes mellitus
were significantly associated with CAVI scores. It is im-
plied that the extent of arteriosclerosis (including arterial
stiffness and atherosclerosis) was moderately enhanced
among persons with prediabetes and was further ad-
vanced among persons with diabetes. Thus, it is import-
ant to introduce earlier interventions for changing
lifestyle and diet of persons with prediabetes in order to
prevent them from developing diabetes and further ad-
vancing arteriosclerosis.
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